Randomized Study of TransAeris® System in Cardiac Surgery Patients at Risk of Prolonged Mechanical Ventilation
Status unknown · Not applicable · NCT04899856
Conditions: Ventilator Induced Diaphragm Dysfunction
At a glance
- Research payments reported, 2025
- $57,130
- U.S. investigators named
- 0
- Sites paid
- 1
- Planned or actual enrollment
- 40
About the trial
- Sponsor
- Synapse Biomedical
- Tested
- TransAeris (device)
- Dates
- Started 2021-08-10; completion 2024-05
- Results posted
- Not yet
This study will be conducted as a randomized trial of the TransAeris system for the prevention and treatment of ventilator-induced diaphragm dysfunction (VIDD) in patients identified prior to surgery to be at greater risk of prolonged mechanical ventilation (PMV).
From ClinicalTrials.gov, last updated 2023-08-18. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Synapse Biomedical Inc reported $57,130 in research payments for this study in 2025 (1 payments).
Products named: Transaeris
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
Sites paid to run it
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.